BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11822325)

  • 1. Constitutional protection of commercial speech under the Central Hudson test as applied to health claims.
    Schramm MJ
    Food Drug Law J; 1996; 51(2):323-9. PubMed ID: 11822325
    [No Abstract]   [Full Text] [Related]  

  • 2. A global view of the First Amendment constraints of FDA.
    Carver KH
    Food Drug Law J; 2008; 63(1):151-215. PubMed ID: 18561459
    [No Abstract]   [Full Text] [Related]  

  • 3. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 4. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract]   [Full Text] [Related]  

  • 6. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
    Helmanis AM
    Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
    [No Abstract]   [Full Text] [Related]  

  • 7. The WLF case thus far: not with a bang, but a whimper.
    Cooper RM
    Food Drug Law J; 2000; 55(4):477-89. PubMed ID: 12025847
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 9. The First Amendment and federal court deference to the Food and Drug Administration: The Times They Are A-Changin'.
    Basile EM; Gross M
    Food Drug Law J; 2004; 59(1):31-44. PubMed ID: 15190924
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
    Villafranco JE; Lustigman AB
    Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
    [No Abstract]   [Full Text] [Related]  

  • 11. Surfing the Net in shallow waters: product liability concerns and advertising on the Internet.
    Moberg MA; Wood JW; Dorfman HL
    Food Drug Law J; 1998; 53(2):213-24. PubMed ID: 10346682
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA marketing v. First Amendment: Washington Legal Foundation legal challenges to off-label policies may force unprecedented changes at FDA.
    Kamp J; Troy DE; Alexander E
    Food Drug Law J; 1999; 54(4):555-65. PubMed ID: 11824453
    [No Abstract]   [Full Text] [Related]  

  • 13. The Supreme Court checks out drug promotion restrictions.
    Gilhooley M
    Food Drug Law J; 2003; 58(3):347-52. PubMed ID: 14626982
    [No Abstract]   [Full Text] [Related]  

  • 14. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 15. The end of paternalism: a new approach to food labeling.
    Steinborn SB; Todd KA
    Food Drug Law J; 1999; 54(3):401-22. PubMed ID: 11797706
    [No Abstract]   [Full Text] [Related]  

  • 16. The Dietary Supplement Health and Education Act.
    Young AL; Bass IS
    Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of dietary supplements: five years of DSHEA.
    Khatcheressian LA
    Food Drug Law J; 1999; 54(4):623-44. PubMed ID: 11824458
    [No Abstract]   [Full Text] [Related]  

  • 18. The butt stops here: the Tobacco Control Act's anti-smoking regulations run afoul of the First Amendment.
    Weatherby D; Day TR
    Albany Law Rev; 2012-2013; 76(1):121-65. PubMed ID: 23577376
    [No Abstract]   [Full Text] [Related]  

  • 19. Legal overview of likely FDA regulation of Internet promotion.
    Scheineson MJ
    Food Drug Law J; 1996; 51(4):697-716. PubMed ID: 11797736
    [No Abstract]   [Full Text] [Related]  

  • 20. The First Amendment and the Food and Drug Administration's regulation of labeling and advertising: three proposed reforms.
    Kahan JS; Shapiro JK
    Food Drug Law J; 2003; 58(3):353-64. PubMed ID: 14626983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.